Long-term follow-up of 2 patients treated with 90Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.

Authors : Golstein SC, Muylle K, Vercruyssen M, Spilleboudt C, de Wind A, Bron D
Year : 2018
Journal : Eur J Haematol
Volume : 101
Pages : 415-417